chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician and a nurse concerning an approximately 19 year old female patient who on approximately 28-DEC-2009 (in the last week) was vaccinated "in the mid to post lateral part of the thigh" with a 0.5 ml third dose of GARDASIL (Lot number not reported), IM. The physician reported that the patient "passed out" after being given her third dose of GARDASIL. The patient recovered on the same day she got vaccinated. The patient sought medical attention. Additional information has been requested.
Fever, extreme aches, shallow breathing, dark urine, fatigue, joint pain.  Patient had had Covid three months prior (mid-November).  Vaccine side effects were the same as when he had Covid and lasted 36 hours.
Arm red - warm, hot to touch, painful. Started on Tequin on 12-2-05.
At 28 weeks pregnant, I received the flu vaccine. The injection was given in my right lateral shoulder, I immediately felt that it did not feel like it was in the muscle and there was a sharp pain different than I've had in other injections. A month later, I continue to have pain in my right shoulder when lifting my arm above my head or bearing weight on the right arm.
Breathing faster; Little fatigue in his legs; Blood pressure was higher than normal; A spontaneous report was received from a Healthcare Professional concerning a 72-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events breathing faster, little fatigue in his legs, blood pressure was higher than normal.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 1 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 027LZ0A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 1 Feb 2021, the patient experienced the events breathing faster. little fatigue in his legs, blood pressure was higher than normal.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events include, breathing faster, little fatigue in his legs, blood pressure was higher than normal was not reported.
bad reaction; delusions; stomach problems; chills; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (bad reaction), DELUSION (delusions), DYSPEPSIA (stomach problems) and CHILLS (chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced ADVERSE REACTION (bad reaction), DELUSION (delusions), DYSPEPSIA (stomach problems) and CHILLS (chills). On 28-Feb-2021, ADVERSE REACTION (bad reaction), DELUSION (delusions), DYSPEPSIA (stomach problems) and CHILLS (chills) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
While patient was seated on exam table 2nd dose GARDASIL 9 given (L) deltoid. Approx. 2 min later pt slumped onto table and as he was being placed in supine position he began having tonic clonic movements which lasted approx. less than 5 seconds then stopped. Pt was responsive but tired. Kept in supine position for 15 to 20 min after event. Pt felt fine afterwards. Was D/C home. Vitals stable.
Injection Site Reaction (Swelling and Redness at Site),  Reported to the Pharmacy 2 days post vaccine administration. No hives or breathing issues.
She had fever; chills; aches; small rash around the injection site; vertigo; Doesn't feel good; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (She had fever), CHILLS (chills), MYALGIA (aches), VACCINATION SITE RASH (small rash around the injection site) and VERTIGO (vertigo) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On an unknown date, the patient experienced PYREXIA (She had fever), CHILLS (chills), MYALGIA (aches), VACCINATION SITE RASH (small rash around the injection site), VERTIGO (vertigo) and MALAISE (Doesn't feel good). At the time of the report, PYREXIA (She had fever), CHILLS (chills) and MYALGIA (aches) had resolved and VACCINATION SITE RASH (small rash around the injection site), VERTIGO (vertigo) and MALAISE (Doesn't feel good) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.
Information has been received from a licensed practical nurse concerning a 9 year old pt who was vacicnated with varicella virus vaccine live. Subsequently the pt developed a breakthrough varicella rash. The pt did not seek medical attention. Additional info has been requested.
Information has been received on 14-MAY-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 19-OCT-2007, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a medical office as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did function as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 13-JUN2016, the patient was treated in a medical office for a blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
Patient's husband noted a large red area at site of injection. Localized, softball sized wheal with a central induration, well defined border. Blanches, edematous and erythematous, nontender to palpation, pt reports minor itchiness.
Vaccine "felt thick" to patient when injected. Reaction began with arm itching, progressed to all over itching, rash, and wheezing within 10 minutes of vaccination. Rec'd IM Benadryl in opposite arm.
intense fever, chills, discomfort onset 2 hours after vaccine dose and ending about 24 hours after vaccine dose. Treatment: bedrest, over the counter tylenol and fluids.
Patient got flu shot on 9/30/10 signed and listed with no allergies, had flu shot in the back. He came into the phx on 10/05 110 and his site of injection and around area has bruised up. He went to the doctor, apparently he's on PLAVIX and NP thinks it might be internal bleed and worsen by PLAVIX.
Patient indicates little soreness next day after injection on 8/12/2020. On 8/13/2020, patient woke up to redness/swelling/pain/warm to touch area around injection site approx 3-4 inch diameter. Patient concerned because no previous reaction to a flu shot and went to urgent care for assessment. Patient received rx for Keflex 500mg BID x 7 days.
Sudden onset of frequent and ongoing heart palpitations and dizzy spells.  Patient is still being tested to determine condition.  Testing has included heart monitor for 2 weeks and an echo cardiogram.  Occurrences happen multiple times per minute all day.  This was not happening prior to the 2nd dose of vaccine.
shingles, got them worse than ever; This case was reported by a consumer and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (patient had shingles twice and they hurt like heck).   On an unknown date, the patient received Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had shingles twice and they hurt like heck. Then the patient got the vaccine and almost immediately got the shingles again worse than ever which the physician said it should not be happen. The follow up was not required.
Burning lungs; Constant cough; Headache; Chills; Stomach pains; Toe blisters; Finger pain; Burning lungs; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9269), via an unspecified route of administration in the left arm on 14Feb2021 at 09:45 (at the age of 75-years-old), as a single dose for COVID-19 immunisation. Medical history included penicillin allergy, allergy (mouthwash allergy), sulfonamide allergy (sulfa drugs) and covid-19. Concomitant medications included acetylsalicylic acid (ASPIRIN) 325 mg one pill per day taken for an unknown indication started from an unknown date. The patient previously took lidocaine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Feb2021 at 10:00, the patient experienced burning lungs, constant cough, headache, chills, stomach pains, toe blisters and finger pain. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events burning lungs, constant cough, headache, chills, stomach pains, toe blisters and finger pain. The clinical outcomes of the events Disorder lung, Cough, headache, chills, stomach pain, blisters, pain in fingers and burning sensation were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Patient came to the rheumatology clinic in June  2021 with right hand swelling over the dorsal surface. Initial MRI showed bone marrow edema and soft tissue edema but no tenosynovitis. Stated swelling occurred after second covid shot in April 2021.  Edema has been improving and bone marrow changes resolved on MRI in October 2021 and only soft tissue swelling and enhancement remained. Family reached out that hand became more swollen on 1/31/22 after receiving covid booster on 1/29/22.  Family again reached out on 2/1/22 and said swelling  has significantly improved but still there.
Headache, pain in chest, increased blood pressure, systolic reading increased to 210 day of vaccination (unsure of diastolic reading). Today blood pressure 155/107.  Patient went to healthcare facility on 4/12/21. was prescribed ASA, Xanax 0.25mg and Norvasc 2.5mg. Headache and chest pain resolved. Patient takes log of blood pressure readings daily. 4/16/21 Follow up: Patient stated as of this morning her BP is 140/109 , chest pain has subsided but she feels its related to gas, headache has also subsided. Advised her to continue with the meds she is taking and also advised her that she can take a gas-x otc to help to relieve some of the bloating and gas feeling she has. Will follow up on Monday 4/19/21.
No adverse event; Report that vaccination 06/02 with expiration date 05/30/Expired vaccine administered 6/2/23 and expired on 5/30/23; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Report that vaccination 06/02 with expiration date 05/30/Expired vaccine administered 6/2/23 and expired on 5/30/23) and NO ADVERSE EVENT (No adverse event) in a 44-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 020H22A) for COVID-19 prophylaxis.     Information related to medical history, conditions, allergy, concomitant diseases and risk factor was reported as not applicable.     On 02-Jun-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 02-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Report that vaccination 06/02 with expiration date 05/30/Expired vaccine administered 6/2/23 and expired on 5/30/23). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Report that vaccination 06/02 with expiration date 05/30/Expired vaccine administered 6/2/23 and expired on 5/30/23) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Report that vaccination 06/02 with expiration date 05/30/Expired vaccine administered 6/2/23 and expired on 5/30/23).    Concomitant medications were not reported.  Patient had expired vaccine on 02-JUN-2023.  Patient had not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-Jun-2023: Live follow up received is significant. Case was updated. Where the reaction occurred was  updated.
Approximately 14x12cm, erythema left upper arm.  Emperic reaction with antibiotics though felt most likely vaccine reaction.  Developed approximately 48 hours after immunization.
I exp really bad nausea, diarrhea, vomiting lasted 3 days.
Cough; Weakness generalized; COVID-19 virus test positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive), COUGH (Cough) and ASTHENIA (Weakness generalized) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for an unknown indication.    No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive), COUGH (Cough) and ASTHENIA (Weakness generalized). At the time of the report, SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive) was resolving and COUGH (Cough) and ASTHENIA (Weakness generalized) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) Positive.         Concomitant medication was not provided.  Treatment medication information was not provided by the reporter.  Primary reporter did not have the lot number information, because the packaging was discarded. It was unknown if patient was enrolled in a COVID-19 vaccine trial.   This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna mailbox were missed to be booked-in.
Itchy skin/scalp; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0162) via an unspecified route of administration on 19Apr2021 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 30Apr2021, the patient had itchy skin and scalp. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events itchy skin and scalp was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
pt recvd vax & was taken back to clinic for convuls; to hosp w/fever of unknown origin, 18AUG DC from hosp
Information has been received from a physician concerning a 12 month old male who on 5/15/02 was vaccinated with the first dose of MMR II (641456/0004M). In May 2002, the pt experienced a rash without a fever. The physician did a strep optical immunoassay test, which resulted as negative. Subsequently, the pt recovered from the rash. The reporter felt that rash was not from strep and was related to therapy with MMR II. Additional info has been requested.
The following day May 12th my shoulder was swollen body ache and I couldn't do anything. I was feeling really sick, around the 13th I had this dry cough. I took Tylenol Theraflu and by then I was feeling like i had the flu. I took over the counter medication but nothing was working. Around 15/16th by then I couldn't even climb the stairs anymore and I live on the 3rd floor. So the 16/17 I was still taking over the counter medication since I was coughing. Around the 22nd I called my primary care doctor and told them what was happening and asked they call in a prescription for the cough because my chest would hurt when I cough. on 22nd/23/24 I started taking the medication in the morning. The Dr said call on the 24th to come in but they were short and I couldn't get in. So I called my daughter to take me to the emergency room. I got there around 11 something. They took my vital signs and sent me for a chest x-ray. They drew my blood. They also gave me an EKG. When I told them what happened and the physician assistant said that there was fluid around my heart per the chest x-ray and asked if I had any issues. I said no because I just did my physical and everything was find. They did an echocardiogram. The Cardiologist came and told me that there was fluid around my heart and they need to remove it through a procedure. They took me to the OR and did the procedure and I stayed in the hospital for 4 days. They said from all the tests and looked for autoimmune disease, viruses everything and they said there was nothing and that they couldn't find anything that would cause this besides the vaccine.
In September, I started waking up every day with stiff painful fingers and it has continued.  At about that time, I also developed sever tail bone pain.  I am currently under the care of a Rheumatologist to determine if I have an autoimmune disease.
started h/a & mild fever later that evening used advil w/minimal results;sx resolved p/3-4 days;
I was fine when I woke up the morning of 11/18. At 8:30 I got out of the car to go shoppling and the feedback from my left leg was strange. It felt dead. I did my shopping, then drove to another store at  9:30. While driving, my left thigh became very numb. I called my GP, and while I had no other signs of stroke or heart attack, she suggested that I go to the ER. The left thigh continued to be numb but varied in intensity and location of the numbness. My left arm and left side of my face also felt tingley or numb. Today, 11/29,  I am still feeling numbness on the left side, but it varies in location and intensity throughout the day. On the 19th I reviewed the health records that I keep on my computer. It turns that I had burning or numbness on the left side (thigh, arm, face) in 1997. My neurologist prescibed amytriptylene, but it made my muscles twitch/spasm so I stopped it. I began acupuncture treatments in 1997 and the symptoms gradually dissappeared. I still get acupuncture treatments monthly.  I sometimes have minor numbness if I am tired, stressed, or sick, but nothing as severe as what I experienced on the 18th. My current level of symptoms is better than on the 18th but worse than I had had in the past 25 years.
Wednesday morning when I woke up I had severe body pain; Barely walk; Lymph node under the left arm swelled up the size of a water balloon.; Severe fatigue; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO150), via an unspecified route of administration in the left arm on 06Apr2021 at 10:45 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma, hypertension, COVID-19, shellfish allergy and allergy to nuts. Concomitant medications included clonidine (MANUFACTURER UNKNOWN) 0.1mg, 3 times a day and amlodipine (MANUFACTURER UNKNOWN) 10 mg, once a day; both from unknown dates for unspecified indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 14:00, the patient experienced severe fatigue Tuesday evening. On 07Apr2021, Wednesday morning when the patient woke up, had severe body pain and could barely walk, Wednesday evening into the night, the patient's lymph node under the left arm swelled up the size of a water balloon. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events severe fatigue, had severe body pain, could barely walk and lymph node under the left arm swelled up the size of a water balloon were resolving at the time of reporting.   No follow-up attempts are needed. No further information is expected.
throat swole but didn't close, was uncomfortable; throat swole but didn't close, was uncomfortable; face got tingling; This is a spontaneous report from a contactable consumer, the patient. A male patient of an unspecified age received first dose of bnt162b2 (Solution for injection), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. Medical history included hypersensitivity (He has a lot of environmental and food allergies), food allergy. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced throat swole but didn't close, was uncomfortable, face got tingling. The caller took the covid vaccine on Friday and had an immediate reaction; throat swole but didn't close, was uncomfortable, face got tingling. He has a lot of environmental and food allergies and knew he was having a reaction. He rates it as a 3/10, it lasted 3 hours, it was tolerable. The patient did not receive any treatment for the events. The clinical outcomes of the throat swole but didn't close, was uncomfortable, face got tingling were unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.